Dicot Pharma AB (STO:DICOT)
0.3540
+0.0020 (0.57%)
At close: Dec 5, 2025
Dicot Pharma AB Market Cap
Dicot Pharma AB has a market cap or net worth of 711.31 million as of December 5, 2025. Its market cap has increased by 81.77% in one year.
Market Cap
711.31M
Enterprise Value
697.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since June 20, 2018, Dicot Pharma AB's market cap has increased from 63.22M to 711.31M, an increase of 1,025.18%. That is a compound annual growth rate of 38.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 711.31M | 64.90% |
| Dec 30, 2024 | 431.35M | 65.92% |
| Dec 29, 2023 | 259.98M | 464.37% |
| Dec 30, 2022 | 46.07M | -35.49% |
| Dec 30, 2021 | 71.41M | 56.49% |
| Dec 30, 2020 | 45.63M | -0.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 118.22B |
| Getinge AB | 57.52B |
| Sectra AB | 52.91B |
| Camurus AB | 35.97B |
| Asker Healthcare Group AB | 34.84B |
| Medicover AB | 34.29B |
| BioArctic AB | 27.25B |
| AddLife AB | 21.90B |